Nrf2 activation induces mitophagy and reverses Parkin/Pink1 knock down-mediated neuronal and muscle degeneration phenotypes
You forget, you travel, something comes up
From July 2026, Wegovy tablets are available for weight management in adults with a BMI greater than 30 or a BMI greater than 27 plus at least one weight-related condition
It may be particularly suitable for researchers who have had difficulty tolerating other weight loss peptides or those who are using retatrutide for metabolic benefits beyond weight loss
Less willing to cooperate
This includes check-ins, 24/7 access to a care team for any questions, and educational resources and support with their nutrition, mental health, and physical well-being through the app